In Part I of this series, we explored the dynamic changes in the regulatory and business landscape within the behavioral health industry since the arrival of the COVID-19 pandemic. One significant obstacle to effective and accessible substance use treatment has been the presence of outdated and ineffective regulations.
The World Health Organization (WHO) has officially lifted the global emergency declaration related to the COVID-19 pandemic, indicating a positive trend in containing the spread of the virus worldwide. Additionally, the United States' public health emergency has also ended. As a result, healthcare providers, including treatment providers, are navigating a new world with significant changes compared to the early months of 2020. The COVID-19 pandemic has led to widespread changes in the healthcare industry, including the adoption of new protocols and technologies, which providers must continue to adapt to moving forward.
